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Abstract: 
Reduced ovarian hormone levels associated with menopause or ovariectomy (OVX) not 
only result in vascular dysfunction but also lead to structural abnormalities in capillaries. There-
fore, the effect of OVX on the three-dimensional (3-D) architecture of capillary networks and 
the underlying molecular mechanisms were investigated in rat soleus muscle. Seven-week-old 
female Wistar rats were divided into the OVX and sham-treated (Sham) groups. The OVX 
group exhibited lower endurance exercise capacity compared to the sham group and resulted in 
decreased capillary diameter, the number of anastomoses and capillary / anastomosis volume in 
soleus muscle, indicating 3-D structural abnormalities of capillary networks. Furthermore, OVX 
led to increased concentrations of thrombospondin-1 (TSP-1) protein and a decreased VEGF-
A/TSP-1 ratio, an indicator of angio-adaptations, in soleus muscle compared with the Sham 
group. These results indicate OVX may induce 3-D capillary regression in soleus muscle 
through an imbalance between VEGF-A and TSP-1 expression, possibly associated with de-
creased exercise tolerance in ovariectomized rats.  
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1. Introduction 
 
Decreased levels of ovarian hormones 
have been reported to be frequently associat-
ed with vascular-related diseases in post-
menopausal women [1]. In the context of this, 
a decrease in ovarian hormones has been 
shown to seriously affect microvasculature in 
brain and heart. In experimental rodent mod-
els of the postmenopausal state, ovarian hor-
mone deficiency induced by ovariectomy 
(OVX) results in abnormalities in capillaries 
of the brain [2], heart [3, 4] and dura mater [5, 
6]. As ovarian hormones circulate through the 
capillaries of the entire body, a decrease in 
ovarian hormones may also impact on the 
microvasculature of the other peripheral or-
gans or tissues, such as skeletal muscle. Sev-
eral studies suggested a reduced ovarian hor-
mone due to menopause was closely associat-
ed with the development of peripheral arterial 
disease [7-9], which limits the function of 
skeletal muscle owing to abnormalities of 
muscle microvasculature [10]. However, the 
influence of ovarian hormone loss due to 
OVX on the microvasculature of skeletal 
muscles remains largely unknown. 
The capillaries of skeletal muscle 
play an important role in supplying oxygen 
and nutrients to and removing waste products 
from muscle cells. Therefore, abnormalities 
of muscle microvasculature can lead to a loss 
of functional capillaries, resulting in a de-
crease in the maximal capacity for delivery of 
oxygen and substrates to muscle cells. A 
number of studies suggested that a decrease in 
muscle capillarity has been shown to serious-
ly impair endurance capacity [10-13] Fur-
thermore, muscle capillarity has been shown 
to determine exercise tolerance also in most if 
not all cardiovascular diseases, including 
heart failure and peripheral arterial disease 
[10, 14-16]. 
Muscle capillarity is susceptible to 
structural change in response to various con-
ditions. Exercise lead to expansion of the ca-
pillary bed [17], while disuse [18, 19] and 
diabetes [20] contributes to abnormal altera-
tion of that. Capillary remodelling in skeletal 
muscle reveals not only cross-sectional 
changes in the number of capillaries but also 
three-dimensional (3-D) structural alterations 
of capillary networks, i.e. capillary volume, 
diameter, tortuosity and the number of anas-
tomoses [18]. In addition, 3-D capillary alter-
ation is not always accompanied by a de-
crease in the number of capillaries observed 
in tissue cross-sections [21]. Hence, the anal-
ysis of 3-D capillary architecture is thought to 
be more useful approach for elucidating rela-
tive changes in muscle capillarity associated 
with a variety of conditions relative to tradi-
tional methods based on two-dimensional 
analysis of muscle capillarity. To date, no in-
formation is available about the effect of 
OVX on the 3-D architecture of microvascu-
lature in skeletal muscle. Therefore, in the 
present study, we used 3-D analysis to visual-
ize structural alterations in the capillary net-
work of skeletal muscles in OVX animals. 
Capillary architecture is tightly regu-
lated by pro- and anti-angiogenic factors in 
skeletal muscle. Vascular endothelial growth 
factor-A (VEGF-A) plays an important role in 
angiogenesis [13, 17, 22], whereas thrombos-
pondin-1 (TSP-1) plays a role in repressing 
capillary growth owing to anti-proliferative 
and pro-apoptotic effects [1, 12, 23-25]. A key 
role for these factors has been well reported 
in the alterations of muscle capillaries in re-
sponse to a variety of conditions including 
exercise [12, 13], peripheral arterial disease 
[26, 27], disuse [19, 28] and diabetes [21, 29]. 
As yet, little is known about the effect of 
OVX on the expression of pro-angiogenic 
VEGF-A and anti-angiogenic TSP-1 in skele-
tal muscle. 
Therefore, the aim of the present 
study was to investigate changes in the 3-D 
architecture of capillaries and associated mo-
lecular mechanisms, in the soleus muscle of 
OVX rats, an experimental model of ovarian 
hormone-deficient women.  
 
 
2. Materials and Methods 
 
2.1. Animals and protocol 
Seven-week-old female Wistar rats 
(Japan SLC, Shizuoka, Japan) weighing 137–
157 g were used. The animals were randomly 
divided into 2 groups: sham-operated group 
3 
(Sham; n = 7) and OVX group (n = 7). Bilat-
eral ovariectomy was performed dorsally un-
der anaesthesia (sodium pentobarbital, 50 
mg/kg, i.p.). Sham operations were performed 
by exteriorizing the ovaries. All animals were 
housed at a temperature of 22 ± 2°C with a 
12–12 h light-dark cycle and provided stand-
ard rodent chow and water ad libitum. Exer-
cise tolerance was assessed 28 weeks after 
surgery using a treadmill exercise test. Two 
weeks after the test, animals were sacrificed 
and the soleus muscle was excised for subse-
quent measurements. This study was ap-
proved by the Institutional Animal Care and 
Use Committee and carried out according to 
the Kobe University Animal Experimentation 
Regulations. All experiments were conducted 
in accordance with the National Institute of 
Health Guide for the Care and Use of Labora-
tory Animals (National Research Council, 
1996). 
 
2.2. Treadmill exercise test 
Treadmill exhausting test was per-
formed to measure maximal running endur-
ance capacity. Rats were trained over the 
course of a week, 5 min/day at a constant 
speed of 10 m/min with no slope to run on an 
adapted motor-driven treadmill designed for 
rats. After adapting to the treadmill, the rats 
ran on a treadmill with a slope of 20° at a 
constant speed of 15 m/min until exhaustion 
[30]. Stainless-steel grids provided an electri-
cal stimulus that encouraged running. Ex-
haustion was established when rats accepted 3 
consecutive electrical stimuli instead of run-
ning. Blood lactate levels were measured 
from tail vein blood samples using Lactate 
Pro (Arkley, Kyoto, Japan) before and after 
the treadmill endurance test. 
 
2.3. Tissue extraction 
After 30 weeks, animals were anaes-
thetized with sodium pentobarbital (50 
mg/kg, i.p.), and heparin (5,000 IU/kg, i.p.) 
was injected. Animals were placed on a heat-
ed surgical table, laparotomy was performed, 
and the uterus and associated white adipose 
tissue were removed and weighed after con-
nective tissue was dissected. Subsequently, 
the left soleus muscle was removed, blotted 
dry and weighed. Muscle tissue was mounted 
on cork, rapidly frozen in an isopentane 
cooled in dry ice and stored at −80°C until 
histological and biochemical analyses. Then, 
for 3-D imaging of soleus capillary architec-
ture, the right soleus muscle was perfused 
with a contrast medium consisting of 1% flu-
orescent material (Tombow, Tokyo, Japan), 
8% gelatin (Nacalai Tesque, Kyoto, Japan) 
and distilled water using an established pro-
cedure described in previous studies [18-20]. 
After the animals were sacrificed, the entire 
body of the rat was immersed into cold saline 
for 15 min. Thereafter, the right soleus muscle 
was removed, blotted dry, mounted on cork of 
near-physiological length, rapidly frozen in 
isopentane cooled in dry ice and stored at 
−80°C until analyses in 3-D architecture of 
capillary network.  
 
2.4. Histochemical analysis 
Left soleus muscles were sliced into 
12-μm thick transverse sections using a cryo-
stat microtome (CM-1510S, Leica Microsys-
tems, Mannheim, Germany). Sections were 
stained with alkaline phosphatase (AP) to 
visualize capillaries in the soleus muscle. Sec-
tions were incubated in 0.1% 5-bromo-4-
chloro-3-indolyl phosphate/nitro blue tetrazo-
lium for 45 min at 37°C and fixed with 4% 
paraformaldehyde, as previously described 
[28, 31]. The mean fibre cross-sectional area 
was determined for 300–500 fibres per mus-
cle using microscopic images of AP staining. 
The capillary density was measured by count-
ing all capillaries in a 1-mm2 muscle cross-
section. All measurements were performed 
using NIH ImageJ software program (NIH, 
Bethesda, MD, USA). 
 
2.5. Three-dimensional visualization of the 
capillary network 
To visualize 3-D capillary architec-
ture in soleus muscle, a confocal laser scan-
ning microscope (C2, Nikon, Tokyo, Japan) 
with an argon laser (488 nm) was used, as 
previously described [18-20]. Briefly, the 
sample block of the right soleus muscle was 
longitudinally sliced into 100 μm sections 
using a cryostat (CM-1510S, Leica Microsys-
tems, Mannheim, Germany). Microscopic 3-
4 
D capillary images were obtained at a magni-
fication of 20× and scanned in 1-μm thick 
longitudinal slices over a total depth of 50 
μm. To visualize the 3-D architecture of capil-
lary networks, the 50 files were stacked and 
converted into digital images. Using 3-D im-
ages of capillary networks, capillary diameter, 
the number of anastomoses and capillary / 
anastomosis volume were measured in vol-
ume of 2 mm3 (200 μm length, 200 μm width 
and 50 μm depth) using NIH ImageJ software 
(NIH, Bethesda, MD, USA). All measure-
ments were performed using 7–10 stacked 
images per muscle.  
 
2.6. Citrate synthase and β-hydroxyacyl-
CoA dehydrogenase activities 
Citrate synthase (CS) activity was 
measured from the left soleus muscle. The 
sample was homogenized in 10-mM Tris (pH 
7.4), 175-mM KCl and 2-mM EDTA. Ho-
mogenates were frozen and thawed thrice and 
then centrifuged at 15,000g for 10 min at 4°C. 
Supernatants were collected and used for the 
measuring the CS activity by Srere’s method 
[32]. Briefly, supernatants were reacted with 
5-mM oxaloacetate after addition of 100-mM 
Tris (pH 7.4), 3-mM acetyl-CoA, 1-mM 5, 5’-
dithobis [2-nitrobenzoric acid] (DTNB) and 
absorbance measured at 412 nm for 5 min. 
β-hydroxyacyl-CoA dehydrogenase (β-
HAD) activity was measured from samples 
prepared for the CS assay. Measurements 
were performed using Bass’s method [33]. 
Briefly, supernatants were reacted with 0.1-
mM acetoacetyl-CoA after addition of 167-
mM triethanolamine (pH 7.4), 50-mM EDTA 
and 0.3-mM NADH, and absorbance meas-
ured at 340nm for 5 min. 
 
2.7. Western blotting 
Portions (approximately 20 mg) of 
each left soleus muscle were homogenized in 
RIPA lysis buffer containing 1-mM Na3VO4, 
1-mM NaF and protease inhibitor cocktail 
(1:100, P8340; Sigma Chemicals, Perth, WA, 
USA). Total supernatant protein concentra-
tions were determined according to Bradford 
method using a protein assay kit (Bio-Rad 
Laboratories, Hercules, CA, USA) before 
loading onto either 7.5% (40 μg/lane) or 
12.5% (20 μg/lane) SDS-polyacrylamide gels. 
Proteins were blotted on polyvinylidene 
difluoride (PVDF) membranes and blocked 
for 1 h with 5% skimmed milk in PBS with 
0.1% Tween 20 (PBST). Membranes were 
incubated using antibodies against VEGF-A 
(1:200 in PBST, sc-7269; Santa Cruz Bio-
technology, Santa Cruz, CA, USA) or TSP-1 
(1:100 in PBST, sc-59887; Santa Cruz Bio-
technology) overnight at 4°C and then incu-
bated in a solution with HRP-conjugated anti-
mouse (1:1000 in PBST, GE Healthcare, 
Waukesha, WI, USA) for 1 h. Proteins were 
detected using EzWestLumi One (ATTO, To-
kyo, Japan). Finally, images were analysed 
with a LAS-1000 (Fujifilm, Tokyo, Japan) 
using a chemiluminescent image analyzer and 
quantified using the Multi-Gauge Image 
Analysis Software program (Fujifilm) against 
a relative concentration of β-actin (1:1000 in 
PBST, sc-47778; Santa Cruz Biotechnology) 
as an internal control. The used primary anti-
bodies, i.e. VEGF-A, TSP-1 and β-actin, in 
this study were appropriate for western blot 
and validated to be used with the experi-
mental subjects in the previous studies [31, 
34]. VEGF-A-to-TSP-1 (VEGF-A/TSP-1) 
ratios were calculated and used to reflect the 
balance between the levels of pro- and anti-
angiogenic factors [28]. 
 
2.8. Statistical analysis 
All values were expressed as mean 
and SEM. Significant differences in blood 
lactate levels in each group between before 
and after exercise testing were analysed by 
the paired Student’s t test. Significant differ-
ences between Sham and OVX groups were 
analysed by unpaired Student’s t test. Results 
were deemed statistically significant level at p 
<0.05. 
 
 
3. Results 
 
3.1. Maximal endurance running capacities 
and plasma lactate levels 
The maximum running endurance 
time in the OVX group was significantly low-
er than that in the Sham group (Fig. 1A). 
There was no difference in plasma lactate 
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Table 1 
Body weight, visceral fat weight and uterus weight 
 
 
Initial 
body weight (g) 
 
Final 
body weight (g) 
Peri-uteral 
adipose tissue 
weight (g) 
 
Uterus weight 
(mg) 
Sham 143 ± 3 238 ± 4 8.7 ± 0.3 539 ± 36 
OVX 143 ± 2 294 ± 7* 10.5 ± 0.3* 80 ± 8* 
Values indicate means ± SEM (n = 7 in each group). The symbol * is significantly different from the 
Sham group, at p ˂0.05. 
 
 
levels before the running test between the 
Sham and OVX groups, but those in both the 
Sham and OVX groups showed a significant 
increase after the running test. Furthermore, 
the plasma lactate level after the running test 
in the OVX group was significantly higher 
than that in the Sham group (Fig. 1B). 
 
3.2. Body weight, visceral fat mass and 
uterus mass 
Final body weights were significantly 
higher in the OVX group than those in the 
Sham group (Table 1). In this study, peri-
uteral adipose tissue and uterus were harvest-
ed to estimate the efficiency of the ovariec-
tomy to reduce ovarian hormone levels. Peri-
uteral adipose tissue weights were significant-
ly higher in the OVX group than in the Sham 
group (Table 1), whereas uterus weights in the 
OVX group were significantly lower than 
those in the Sham group (Table 1).These re-
sults coincide with the previous studies sug-
gesting that significant visceral fat gain and 
uterus atrophy are induced by OVX [35-37]. 
 
 
3.3. Soleus muscle mass, fibre cross-
sectional area and capillary density 
No difference in soleus muscle mass 
or fibre cross-sectional area was observed 
between the Sham and OVX groups (Table 2). 
Additionally, the ratio of capillary density to 
muscle cross-sectional area was similar in 
both groups (Table 2). 
 
3.4. Muscle citrate synthase and β-
hydroxyacyl-CoA dehydrogenase activities 
CS and β-HAD are the key mito-
chondrial enzymes in the tricarboxylic acid 
cycle and β-oxidation of fatty acids, respec-
tively, associated with the oxidative capacity 
of skeletal muscle. There was no significant 
difference in CS activity between the two 
groups (Table 2). However, β-HAD activity 
was significantly higher in the OVX group 
than in the Sham group (Table 2). 
 
3.5. Capillary diameter, the number of 
anastomoses and capillary / anastomosis 
volume 
 
 
 
Fig. 1. The maximal endurance time (A) and the blood lactate levels before and after the treadmill exhausting test 
(B). The values indicate means ± SEM (n = 7 in each group). The symbol # is significantly different from the lactate 
level before the test in the each group, and the symbol † is significantly different from the lactate level after the test in 
the Sham group, respectively, at p <0.05. The following abbreviations are used for Figures 1–3: Sham, sham operat-
ed; OVX, ovariectomized group. 
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The 3-dimensional capillary architec-
ture was analysed using a confocal laser-
scanning microscope as described previously 
[18-20]. Representative confocal images of 
soleus muscle capillaries and intercapillary 
anastomoses from each group are shown in 
Fig. 2A and B. The histogram of luminal ca-
pillary diameter was shown in Fig. 2C and 
those in the OVX group was shifted towards 
reduced capillary diameter compared to that 
of the Sham group, indicating that smaller 
capillaries were more abundant in the OVX 
group. The mean capillary diameter, number 
of anastomoses and capillary / anastomosis 
volume in the OVX group were significantly 
lower than those in the Sham group (Fig. 2D-
F).  
 
 
3.6. Expression levels of VEGF-A and TSP-
1 proteins and the VEGF-A/TSP-1 ratio 
Representative western blots for 
VEGF-A and TSP-1 in soleus muscle from 
Sham and OVX groups are shown in Fig. 3A 
and B. No significant difference in the 
amount of VEGF-A protein was observed 
between the Sham and OVX groups (Fig. 
3A). The amount of TSP-1 protein, however, 
was significantly higher in the OVX group 
than in the Sham group (Fig. 3B). Conse-
quently, the VEGF-A/TSP-1 ratio was signifi-
cantly lower in the OVX group than in the 
Sham group (Fig. 3C).  
 
 
 
Table 2 
Soleus wet weight, fibre cross-sectional area, capillary density and mitochondrial enzyme activities 
 
 
Soleus wet 
weight (mg) 
Fibre cross- 
sectional 
area (μm2) 
Capillary 
density 
(no./mm2) 
 
CS activity 
(nmol/min/mg) 
 
β-HAD activity 
(nmol/min/mg) 
Sham 94 ± 4 2932 ± 120 631 ± 13 179 ± 8 66 ± 3 
OVX 106 ± 5 3276 ± 153 649 ± 25 191 ± 13 77 ± 3* 
Values indicate means ± SEM (n = 7 in each group). The symbol * is significantly different from the 
Sham group, at p ˂0.05. 
 
 
 
 
Fig. 2. Representative images of the capillaries and intercapillary anastomoses architecture of the soleus muscle in 
the Sham (A) and OVX (B) group. Arrows indicate capillaries with a diameter of <2.5 µm and arrowheads show 
intercapillary anastomoses. Image depth (z-axis) = 50 μm; scale bar represents 100 μm. C: Frequency distribution of 
the luminal diameter of the capillaries in the soleus muscles in the Sham and OVX group. Also shown are the mean 
capillary diameter (D), number of anastomoses (E) and capillary / anastomosis volume (F). These measurements 
were determined using a confocal laser scanning microscope. The values indicate means ± SEM (n = 7 in each 
group). The symbol * is significantly different from the Sham group, at p <0.05. 
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4. Discussion 
 
In the present study, we found a de-
crease in capillary diameter, the number of 
anastomoses and capillary / anastomosis vol-
ume of the soleus muscle in the OVX group 
using 3-D capillary network observation. Fur-
thermore, the VEGF-A/TSP-1 ratio was lower 
in the OVX group compared with that in the 
Sham group due to an increase in TSP-1 ex-
pression in soleus muscle. These observations 
indicate that OVX may induce capillary rare-
faction in skeletal muscle due to an associated 
imbalance between pro-angiogenic VEGF-A 
and anti-angiogenic factor TSP-1 levels.  
It has been previously reported that 
exposure to ovarian hormones can promote 
angiogenesis [38], while there is little infor-
mation about the effect of ovarian hormone 
loss on angio-adaptation in skeletal muscle of 
ovariectomized rats. A number of studies have 
reported that OVX-induced muscle impair-
ment results from a deficiency in circulating 
ovarian hormones [37, 39, 40]. In the OVX 
rodent model, ovarian hormone deficiency 
has been reported to induce an increase in 
body and visceral fat mass [35-37]. In addi-
tion, uterus atrophy was observed and used as 
an indicator of ovarian hormone deficiency in 
a previous study [41]. Similarly, our results 
demonstrated increased body and visceral fat 
mass and decreased uteral mass in the OVX 
group, indicating that the OVX group had 
ovarian hormone deficiency in this study.  
 
 
Muscle capillarity is susceptible to 
structural change in response to various con-
ditions. Structural change in capillary net-
works is measured by changes in morpholog-
ical properties including not only capillary 
number but also in capillary diameter, vol-
ume, tortuosity and the number of anastomo-
ses. In the present study, the OVX group had 
decreased capillary diameter, number of anas-
tomoses and capillary / anastomosis volume 
without a decrease in the number of capillar-
ies when compared with those in the Sham 
group. Therefore, this study demonstrates for 
the first time that OVX has an impact of the 
microvasculature of the soleus muscle. 
Skeletal muscle capillaries are neces-
sary for oxygen supply to muscle cells and to 
determine oxygen supply capacity. Therefore, 
capillary structural alteration in skeletal mus-
cle leads to affect oxygen supply to muscle 
cells. The decreased number of muscle capil-
laries, followed by a possibly reduced muscle 
perfusion during exercise, has been shown to 
be closely related with exercise intolerance 
[10-13]. Similarly, the other characters of mi-
crovasculature, including capillary diameter, 
anastomosis number and capillary / anasto-
mosis volume, may also have an impact on 
muscle perfusion during exercise as well as 
the number of muscle capillaries and, addi-
tionally, exercise tolerance. Abnormalities of 
microvasculature were observed as a decrease 
in the capillary diameter, anastomoses num-
ber and capillary / anastomosis volume not in 
 
 
Fig. 3. Protein levels of VEGF-A (A), TSP-1 (B) and the VEGF-A/TSP-1 ratio (C) in the Sham and OVX groups. 
Each protein was quantified in relation to the levels of β-actin proteins from each gel. The expression levels are calcu-
lated as the fold change (in a.u.) relative to the Sham group and indicate means ± SEM (n = 7 in each group). The 
symbol * is significantly different from the Sham group, at p <0.05. 
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the capillary number in soleus muscle of the 
OVX group in this study. In addition, capillar-
ies with a diameter of <2.5 µm, which were 
preventing erythrocyte flow [42], were ob-
served more frequently in the OVX group 
than in the Sham group, suggesting that a 
higher percentage of capillaries in the OVX 
group were unavailable for oxygen supply 
than that in the Sham group. These alterations 
led to a loss of functional capillaries in soleus 
muscle of the OVX group, possibly contrib-
uting to a smaller oxygen supply to muscle 
cells during the maximal exercise test relative 
to the Sham group. Indeed, the OVX group 
exhibited a decrease in exercise endurance 
time and an increase in blood lactate levels 
after the exercise test in this study. On the 
other hand, CS activity, an indicator of mito-
chondrial oxidative capacity, did not differ 
between the Sham and OVX groups. This 
result is consistent with previous studies 
showing that muscle CS activity is unchanged 
between sham- and OVX-treated animals [37, 
40, 43]. β-HAD activity in soleus muscle as 
an indicator of β-oxidation was also investi-
gated. Surprisingly, β-HAD activity in the 
OVX group was higher than that in the Sham 
group. Some studies have shown that OVX 
decreases β-oxidation-related enzymatic ac-
tivities in skeletal muscle [41, 43], whereas 
other studies failed to detect a difference in β-
oxidation enzymes from sham-treated rats 
[40, 44, 45]. From these and previous results, 
there is little consensus on the adaptation of 
muscle β-oxidation enzymes in response to 
ovariectomy. Increased β-HAD activity in the 
OVX group may be related to ovariectomy 
duration in this study. In fact, 30 weeks dura-
tion of OVX is relatively long compared with 
previous studies. Therefore, we could not ex-
clude the possibility that because OVX in-
duces obesity with increased visceral fat, in-
creased β-HAD activity in the OVX group 
could be accounted for by an obesity-related 
muscle adaptation to changes in circulating 
adipokines and free fatty acids [46, 47]. These 
observations indicate that OVX-induced ca-
pillary structural abnormalities, rather than 
mitochondrial alterations in skeletal muscle, 
may contribute to exercise intolerance and 
higher production of lactic acid after maximal 
exercise test in the OVX group. This is likely 
due to significant limitation of oxygen supply 
necessary for endurance exercise, followed by 
higher compensatory anaerobic metabolism.  
Although muscle capillarity is often 
homologous with muscle mitochondrial activ-
ity, the OVX group had higher mitochondrial 
enzyme activity, but a reduced number in 
functional capillaries in soleus muscle in this 
present study. A previous study reported that a 
decrease in muscle capillarity, but an increase 
in muscle oxidative and mitochondrial en-
zyme activities were observed in muscle spe-
cific VEGF-A-deleted mice [13]. Moreover, 
similar observations have been reported in 
muscle dysfunction due to peripheral arterial 
disease [48, 49], chronic obstructive pulmo-
nary disease [50] and obesity [51]. These re-
ports indicate that muscle capillarity is not 
necessarily homologous with muscle mito-
chondrial activity. Therefore, the 3-D capil-
lary remodelling observed in the OVX group 
could not be attributed to changes in muscle 
mitochondrial activity in this study. Since 
ovarian hormones have been shown to be in-
volved in a variety of intercellular signalling 
pathways in skeletal muscle [36, 37, 52, 53], 
decreased ovarian hormone levels induced by 
OVX may influence microvasculature-related 
molecular mechanisms in soleus muscle, par-
ticularly as the OVX group exhibited greater 
3-D capillary rarefaction compared to that 
exhibited by the Sham group.  
VEGF-A is a well-known regulator 
of angiogenesis, stimulating the formation of 
new vascular networks by recruiting and 
promoting differentiation of endothelial cells 
[54]. An increase in VEGF-A expression in-
duces angiogenesis in skeletal muscle, where-
as a decrease in VEGF-A expression results in 
capillary rarefaction. This study found no dif-
ference in the amount of VEGF-A between 
the OVX and Sham groups. Alterations of 
muscle microvasculature are not necessarily 
accompanied by a decrease in VEGF-A levels 
under several conditions [20, 28, 31]. On the 
other hand, the amount of soleus muscle TSP-
1 was significantly higher in the OVX group 
than that in the Sham group in this study. 
TSP-1 is commonly known as an inhibitor of 
angiogenesis and has an anti-proliferative and 
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pro-apoptotic effects [1, 12, 23-25]. An in-
creased TSP-1 expression occurs in the skele-
tal muscle in the context of disuse [19, 28], 
diabetes [21] or peripheral arterial disease 
[26, 27], leading to abnormalities of the mus-
cle microvasculature. Several studies show 
that an increase in TSP-1 expression in skele-
tal muscle induces structural alterations of 
microvasculature, such as decreased perime-
ter, diameter and volume of capillary [21, 55]. 
Furthermore, endothelial cell apoptosis occurs 
more frequently in anastomoses of muscle 
microvessel in the state of angiostatic re-
sponse to disuse [18]. From these results, the 
structural alterations of muscle capillarity 
observed in the OVX group might result from 
the angiostatic effects of TSP-1. Sengupta et 
al. [56] reported that TSP-1 expression is at-
tenuated by oestrogen in human umbilical 
vein endothelial cells. Therefore, higher TSP-
1 expression in the OVX group in our study 
may be partly associated with the loss of the 
inhibitory effect of oestrogen on TSP-1 ex-
pression. In addition, the integrated balance 
between VEGF-A and TSP-1 expression in 
soleus muscle was measured as an indicator 
of muscle angio-adaptions. Consequently, a 
decrease in the VEGF-A/TSP-1 ratio was 
demonstrated in the OVX group, indicating 
an imbalance between pro- and anti-
angiogenic factors induced by OVX. Roudier 
et al. [28] have reported that measurement of 
the VEGF-A/TSP-1 ratio in skeletal muscle is 
a more accurate approach for evaluating mus-
cle angio-adaptations than individual analysis 
of the individual factors. A decrease in the 
VEGF-A/TSP-1 ratio is associated with ab-
normalities of 3-D capillary architecture in 
soleus muscle induced by hindlimb unloading 
in previous studies [19, 28]. Moreover, Kondo 
et al. [21] have demonstrated that a decrease 
in the VEGF-A/TSP-1 ratio contributes to 
decreased capillary diameter and capillary / 
anastomosis volume without a loss of capil-
lary number in soleus muscle of type 2 dia-
betic rats. Based on these observations, de-
creased VEGF-A/TSP-1 ratio due to a variety 
of conditions can lead to a loss of functional 
capillaries due to 3-D capillary remodelling 
involving a decrease in the capillary diameter 
and capillary / anastomosis volume in soleus 
muscle. Therefore, decreased VEGF-A/TSP-1 
ratio induced by OVX may affect the 3-D 
capillary abnormalities observed as decreased 
capillary luminal diameter, the number of 
anastomoses and capillary / anastomoses vol-
ume in the OVX group. In this study, we 
demonstrated the effect of OVX on levels of 
VEGF-A and TSP-1 in rat soleus muscle. 
However, we were unable to demonstrate the 
effects of OVX on other angiogenic factors, 
such as angiopoietins and VEGF-A receptors, 
or confirm whether ovarian hormone loss in-
fluenced signalling pathway involved in an-
gio-adaptation. In the future, further studies 
using estradiol and/or progesterone replace-
ment in OVX rats are required to determine 
the relationship between ovarian hormone 
loss due to OVX and angiogenic molecular 
mechanisms in skeletal muscle in greater de-
tail. 
In conclusion, this study demon-
strates a novel effect of OVX on the architec-
ture of the capillary bed. OVX induces a loss 
of functional capillaries, as shown by a re-
duced diameter and suggests that the underly-
ing mechanism could involve an imbalance 
between pro-angiogenic VEGF-A and anti-
angiogenic TSP-1 expression. The OVX-
induced capillary alterations are likely associ-
ated with muscle perfusion that is resulting in 
a reduced tolerance to exercise. Previous 
studies have shown that postmenopausal 
women and OVX treated rats exhibited de-
creased muscle performance [57, 58]. There-
fore, this study suggests that a loss of func-
tional capillaries in skeletal muscle, associat-
ed with decreased circulating ovarian hor-
mones, may influence muscle metabolic dys-
function, such as exercise intolerance, in 
postmenopausal states. Furthermore, OVX in 
the present study induced exercise intoler-
ance, the abnormal capillarity possibly due to 
the angiostatic effects of TSP-1 and the in-
creased mitochondrial enzyme activity, which 
are similarly observed in the skeletal muscle 
of peripheral arterial disease. Hence, the pre-
sent study demonstrated for the first time that 
OVX could induce peripheral arterial disease-
like alteration in the capillarity and mito-
chondrial activity of skeletal muscle.  
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